Patrice Delafontaine, MD, is dean of the University of Missouri School of Medicine.
A member of the Tulane University faculty from 2003 to 2014, Delafontaine also has served in clinical leadership positions at the University of Kansas Medical Center, the University of Geneva and Emory University in Atlanta. In 2001, he was elected by his peers for inclusion in Best Doctors in America®. Delafontaine’s research on cardiovascular health has been continuously funded by the National Institutes of Health for more than 18 years.
Delafontaine has experience with basic science research, animal studies and clinical and translational research. In 2012, Delafontaine, along with researchers at Louisiana State University and the Pennington Biomedical Research Center, received a five-year $20 million grant from the National Institutes of Health to create a collaborative research initiative dedicated to biomedical research, including cardiovascular disease.
Delafontaine was the first scientist to establish the critical link between the human hormone system that regulates blood pressure, known as the renin-angiotensin system, and a protein that is essential for childhood growth. His studies on this link have provided major new insights into muscle-wasting diseases. He has authored more than 115 articles about his research.
Born in Alexandria, Egypt, Delafontaine received his doctor of medicine degree from the University of Geneva in Geneva, Switzerland. He completed a research and clinical fellowship in medicine (cardiology) at Harvard Medical School and Brigham and Women’s Hospital in Boston.